Galcanezumab in migraine prevention: a systematic review and meta-analysis of randomized controlled trials.

Published in: Therapeutic advances in neurological disorders (2020)

Galcanezumab is an efficacious and well-tolerated preventive treatment for migraine. Larger clinical trials with longer follow-up periods need to be conducted in order to provide more safety data of the above-mentioned drug.

Keyphrases

clinical trial
systematic review
electronic health record
big data
randomized controlled trial
combination therapy
drug induced
open label
phase ii
data analysis
artificial intelligence